Chemo ups metabolic syndrome risk in early-stage breast cancer
(HealthDay)—For patients with early-stage breast cancer with no preexisting metabolic syndrome (MetS), chemotherapy is associated with increased risk of MetS, according to a study published online May 24 in Cancer.
Jun 9, 2016
0
2